Form 8-K - Current report:
SEC Accession No. 0001193125-18-247901
Filing Date
2018-08-14
Accepted
2018-08-14 08:09:10
Documents
2
Period of Report
2018-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d607089d8k.htm 8-K 19529
2 EX-99.1 d607089dex991.htm EX-99.1 10311
  Complete submission text file 0001193125-18-247901.txt   31190
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 181014375
SIC: 2834 Pharmaceutical Preparations